Type
. Do nerve growth factor-related mechanisms contribute to loss of cutaneous nociception in leprosy?. Pain. 2000;85(1-2):231-8.
Type
. Future scope and expectations: why, when, and how LECs should continue. Leprosy review [Internet]. 1999;70(4):498-505. Available from: http://leprev.ilsl.br/pdfs/1999/v70n4/pdf/v70n4a17.pdf
Type
. The Dharavi story--saga of LECs over 2 decades. Leprosy review [Internet]. 1999;70(4):495-7. Available from: http://leprev.ilsl.br/pdfs/1999/v70n4/pdf/v70n4a16.pdf
Type
. Leprosy elimination--sprint or marathon?. Leprosy review [Internet]. 1999;70(4):428-9. Available from: http://leprev.ilsl.br/pdfs/1999/v70n4/pdf/v70n4a06.pdf
Type
Guidelines for carrying out leprosy elimination campaigns 1996. WHO, Action Programme for the Elimination of Leprosy. Leprosy review [Internet]. 1999;70(4):408-27. Available from: http://leprev.ilsl.br/pdfs/1999/v70n4/pdf/v70n4a05.pdf
Type
Leprosy elimination campaigns (LEC). Leprosy review [Internet]. 1999;70(4):404-7. Available from: http://leprev.ilsl.br/pdfs/1999/v70n4/pdf/v70n4a04.pdf
Type
. Disease and stigma. Lancet (London, England). 1999;354 Suppl:SIV15.
Type
. [The program for the elimination of leprosy: ambitious challenges, novel approaches, issues in doubt]. Bulletin et memoires de l'Academie royale de medecine de Belgique. 1999;154(3-4):201-6; discussion 206-7.
Type
. New on-line parameters for analysis of dynamic foot pressures in neuropathic feet of Hansen's disease subjects. Journal of rehabilitation research and development. 1999;36(3):264-72.
Type
. Three-dimensional foot modeling and analysis of stresses in normal and early stage Hansen's disease with muscle paralysis. Journal of rehabilitation research and development. 1999;36(3):252-63.
Pagination
- Previous page
- Page 1555
- Next page